Literature DB >> 31645342

Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Maeve Mullooly1, Samantha Puvanesarajah2, Mark E Sherman3, Melissa A Troester4, Gretchen L Gierach5, Shaoqi Fan5, Ruth M Pfeiffer5, Linnea T Olsson4, Manila Hada5, Erin L Kirk4, Pamela M Vacek6, Donald L Weaver6, John Shepherd7, Amir Mahmoudzadeh8, Jeff Wang9, Serghei Malkov8, Jason M Johnson10, Stephen M Hewitt11, Sally D Herschorn6.   

Abstract

Delayed terminal duct lobular unit (TDLU) involution is associated with elevated mammographic breast density (MD). Both are independent breast cancer risk factors among women with benign breast disease (BBD). Prior digital analyses of normal breast tissues revealed that epithelial nuclear density (END) and TDLU involution are inversely correlated. Accordingly, we examined associations of END, TDLU involution, and MD in BBD clinical biopsies. This study included digitized images of 262 representative image-guided hematoxylin and eosin-stained biopsies from 224 women diagnosed with BBD, enrolled within the cross-sectional BREAST-Stamp project that were visually assessed for TDLU involution (TDLU count/100 mm2, median TDLU span and median acini count per TDLU). A digital algorithm estimated nuclei count per unit epithelial area, or END. Single X-ray absorptiometry of prebiopsy ipsilateral craniocaudal digital mammograms measured global and localized MD surrounding the biopsy region. Adjusted ordinal logistic regression models assessed relationships between tertiles of TDLU and END measures. Analysis of covariance examined mean differences in MD across END tertiles. TDLU measures were positively associated with increasing END tertiles [TDLU count/100 mm2, ORT3vsT1: 3.42, 95% confidence interval (CI), 1.87-6.28; acini count/TDLUT3vsT1, OR: 2.40, 95% CI, 1.39-4.15]. END was significantly associated with localized, but not, global MD. Relationships were most apparent among patients with nonproliferative BBD. These findings suggest that quantitative END reflects different but complementary information to the histologic information captured by visual TDLU and radiologic MD measures and merits continued evaluation in assessing cellularity of breast parenchyma to understand the etiology of BBD. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31645342      PMCID: PMC7357278          DOI: 10.1158/1940-6207.CAPR-19-0120

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  14 in total

1.  Association between mammographic density and age-related lobular involution of the breast.

Authors:  Karthik Ghosh; Lynn C Hartmann; Carol Reynolds; Daniel W Visscher; Kathleen R Brandt; Robert A Vierkant; Christopher G Scott; Derek C Radisky; Thomas A Sellers; V Shane Pankratz; Celine M Vachon
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

Review 2.  Mammographic densities and breast cancer risk.

Authors:  N F Boyd; G A Lockwood; J W Byng; D L Tritchler; M J Yaffe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-12       Impact factor: 4.254

3.  Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.

Authors:  Jonine D Figueroa; Ruth M Pfeiffer; Louise A Brinton; Maya M Palakal; Amy C Degnim; Derek Radisky; Lynn C Hartmann; Marlene H Frost; Melody L Stallings Mann; Daphne Papathomas; Gretchen L Gierach; Stephen M Hewitt; Maire A Duggan; Daniel Visscher; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2016-08-03       Impact factor: 4.872

4.  Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.

Authors:  Valerie A McCormack; Isabel dos Santos Silva
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

5.  Comparison of mammographic density assessed as volumes and areas among women undergoing diagnostic image-guided breast biopsy.

Authors:  Gretchen L Gierach; Berta M Geller; John A Shepherd; Deesha A Patel; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Ruth M Pfeiffer; Bo Fan; Amir Pasha Mahmoudzadeh; Jeff Wang; Jason M Johnson; Sally D Herschorn; Louise A Brinton; Mark E Sherman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-19       Impact factor: 4.254

6.  Circulating sex hormones and terminal duct lobular unit involution of the normal breast.

Authors:  Zeina G Khodr; Mark E Sherman; Ruth M Pfeiffer; Gretchen L Gierach; Louise A Brinton; Roni T Falk; Deesha A Patel; Laura M Linville; Daphne Papathomas; Susan E Clare; Daniel W Visscher; Carolyn Mies; Stephen M Hewitt; Anna Maria V Storniolo; Adrian Rosebrock; Jesus J Caban; Jonine D Figueroa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

7.  Independent association of lobular involution and mammographic breast density with breast cancer risk.

Authors:  Karthik Ghosh; Celine M Vachon; V Shane Pankratz; Robert A Vierkant; Stephanie S Anderson; Kathleen R Brandt; Daniel W Visscher; Carol Reynolds; Marlene H Frost; Lynn C Hartmann
Journal:  J Natl Cancer Inst       Date:  2010-10-29       Impact factor: 13.506

8.  Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma.

Authors:  Rupninder Sandhu; Lynn Chollet-Hinton; Erin L Kirk; Bentley Midkiff; Melissa A Troester
Journal:  Hum Pathol       Date:  2015-10-23       Impact factor: 3.466

9.  Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast.

Authors:  Lynn Chollet-Hinton; Samantha Puvanesarajah; Rupninder Sandhu; Erin L Kirk; Bentley R Midkiff; Karthik Ghosh; Kathleen R Brandt; Christopher G Scott; Gretchen L Gierach; Mark E Sherman; Celine M Vachon; Melissa A Troester
Journal:  Mod Pathol       Date:  2018-02-20       Impact factor: 7.842

Review 10.  Computer-based image analysis in breast pathology.

Authors:  Ziba Gandomkar; Patrick C Brennan; Claudia Mello-Thoms
Journal:  J Pathol Inform       Date:  2016-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.